New vaccines for a safer world

CEPI works to develop vaccines against emerging infectious diseases. Our latest funding call aims to develop and manufacture proven vaccine technology for use against 2019-nCoV.

Learn more about COVID-19

The rapid global spread and epidemiological characteristics of COVID-19 are deeply concerning. CEPI has moved quickly and urgently to coordinate with global health authorities and partners to rapidly develop vaccine candidates against the disease.

We want to create a world in which epidemics are no longer a threat to humanity.

CEPI wants to galvanise the development of new vaccines against diseases we know could cause the next devastating epidemic.

Our approach

$570bn

The estimated annual global cost of moderately severe to severe pandemics

Eleven

The number of diseases WHO identified as public health risks due to epidemic potential and lack of biomedical countermeasures

$2.8bn

The minimum average cost for progressing one vaccine against each of WHO’s 11 priority epidemic infectious diseases

Epidemic diseases affect us all. They do not respect borders.

CEPI (pronounced 'seppy') aims to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks.

Ahmedabad, India (Paula Bronstein/Getty Images Reportage)